(Q43451624)

23 November 2017

Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis (English)

1 reference

23 November 2017

0 references

1 reference

Karkkonen K

1

1 reference

PubMed ID

11345216

23 November 2017

Stiernstedt SH

series ordinal

2

1 reference

PubMed ID

11345216

23 November 2017

Karlsson M

series ordinal

3

1 reference

23 November 2017

1 January 2001

1 reference

Scandinavian Journal of Infectious Diseases

23 November 2017

1 reference

23 November 2017

33

1 reference

23 November 2017

4

1 reference

23 November 2017

259-262

1 reference

Chronic meningitis caused by a penicillin-sensitive microorganism?

23 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Therapeutic aspects of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Chronic neurologic manifestations of erythema migrans borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

An epidemiologic study of Lyme disease in southern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

In vitro and in vivo susceptibility of Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655401300077225

10.1080/003655401300077225

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference

PubMed ID

11345216